Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Keloids - Overview
Keloids - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Keloids - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Keloids - Companies Involved in Therapeutics Development
Allianz Pharmascience Ltd
FBM Therapeutics LLC
FirstString Research Inc
Lemonex Inc
Miragen Therapeutics Inc
Next Science Ltd
Phio Pharmaceuticals Corp
siRgen Therapeutics Corp
Siromics Inc
Tumorend LLC
Yuhan Corp
Keloids - Drug Profiles
ALZ-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Ri Oligonucleotide to Inhibit Amphiregulin for Hypertrophied scar and Keloid - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CM-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Keloids - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FBM-5712 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Granexin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LEM-S401 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remlarsen - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RXI-109 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STP-705 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YHC-1113 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Keloids - Dormant Projects
Keloids - Discontinued Products
Keloids - Product Development Milestones
Featured News & Press Releases
Jun 02, 2015: RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology
Apr 29, 2014: RXi Pharmaceuticals Announces Initiation of Phase 2a Keloid Study
Mar 05, 2014: RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders
Dec 04, 2013: RXi Pharmaceuticals Announces mR Data of an Additiol Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period
Nov 18, 2013: RXi Pharmaceuticals and Ethicor Announce the Signing of a Distribution Agreement for RXI-109 in the European Union under the "Specials" Provision
Jun 06, 2013: RXi Pharmaceuticals Announces Positive Results In First Double Blind Study In Healthy Volunteers With RXI-109
Jan 30, 2013: RXi Pharma Completes Enrollment In Second Phase I Trial For RXI-109 Program
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Keloids, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Keloids, H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Keloids - Pipeline by Allianz Pharmascience Ltd, H1 2020
Keloids - Pipeline by FBM Therapeutics LLC, H1 2020
Keloids - Pipeline by FirstString Research Inc, H1 2020
Keloids - Pipeline by Lemonex Inc, H1 2020
Keloids - Pipeline by Miragen Therapeutics Inc, H1 2020
Keloids - Pipeline by Next Science Ltd, H1 2020
Keloids - Pipeline by Phio Pharmaceuticals Corp, H1 2020
Keloids - Pipeline by siRNAgen Therapeutics Corp, H1 2020
Keloids - Pipeline by Sirnaomics Inc, H1 2020
Keloids - Pipeline by Tumorend LLC, H1 2020
Keloids - Pipeline by Yuhan Corp, H1 2020
Keloids - Dormant Projects, H1 2020
Keloids - Discontinued Products, H1 2020